AgomAb Therapeutics N.V. American Depositary Shares
Status: Publicly traded
Direct answer
AgomAb Therapeutics N.V. American Depositary Shares is publicly traded on NASDAQ under the ticker AGMB.
AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist. Its innovative pipeline features several promising candidates, including Ontunisertib (AGMB-129), an orally administered,...
Can you invest in AgomAb Therapeutics N.V. American Depositary Shares?
Yes. AgomAb Therapeutics N.V. American Depositary Shares is publicly traded on NASDAQ under the ticker AGMB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for AgomAb Therapeutics N.V. American Depositary Shares
Detailed equity research is provided by MarketSnap.